Overview
The established approach to evaluating ovarian function relies on serial biochemical hormone analyses. However, the cervicovaginal smear offers a simple, inexpensive and rapid complementary method, since the maturation of squamous epithelium in the female genital tract depends directly on steroid hormones — mainly estrogen.
This lesson explains how the Karyopyknotic Index, Eosinophilic Index and Maturation Index are calculated and interpreted, along with the conditions required for a valid hormonal cytology evaluation.
Learning Objectives
After this lesson you will be able to…- Describe the basics of hormonal assessment using cytology.
- Identify the features of squamous cell maturation.
- Calculate and interpret the Karyopyknotic, Eosinophilic and Maturation Indices.
- List the conditions required before hormonal cytology can be performed.
- Apply cytologic hormonal evaluation to menstrual disorders and other clinical scenarios.
Clinical Story
Why This MattersA 52-year-old woman with irregular bleeding has a vaginal smear evaluated for hormonal status. The report notes a high level of squamous cell maturation, inconsistent with her stated menopausal status — prompting the clinician to investigate for an estrogen-producing tumor or unreported hormone therapy.
Core Concepts
Estrogen produces rapid, complete maturation of squamous epithelium, favoring superficial cells. Complete atrophy equates with absent estrogenic activity. Smears are obtained from the proximal lateral vaginal wall, avoiding contamination from the cervix.
KI expresses the percentage of superficial squamous cells with pyknotic nuclei among all mature squamous cells; it peaks at ovulation (50–85%). EI expresses the percentage of mature cells with eosinophilic cytoplasm regardless of nuclear status; it also peaks near ovulation (50–75%).
MI expresses the ratio of parabasal:intermediate:superficial cells (e.g. 0:35:65 at ovulation). Folded-cell index measures folded-cytoplasm cells among mature cells; crowded-cell index measures cells in clusters of four or more among mature cells.
Valid evaluation requires absence of inflammation/cytolysis, no recent topical/systemic medication affecting epithelium, no radiotherapy/recent surgery, adequate baseline smears across 1–2 cycles, and correct sampling site. Clinical uses include evaluation of amenorrhea, effects of castration, ovarian tumors (e.g. granulosa cell tumors) and precocious puberty.
Laboratory Principle
Estrogen drives proliferation and maturation of vaginal squamous epithelium toward superficial, pyknotic, eosinophilic cells, while progesterone and estrogen withdrawal favor intermediate/parabasal cell predominance. By quantifying the relative proportions of these maturation stages, cytology indirectly reflects the circulating hormonal milieu without requiring blood sampling.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| 95% ethyl alcohol | Wet fixation grade | Immediate smear fixation | Sealed, flammable cabinet |
| Papanicolaou stain | Standard formula | Cell staining for index calculation | Amber bottle, filtered before use |
Step-by-Step Procedure
Verify absence of inflammation, recent medication, radiotherapy or recent surgery affecting the vagina/cervix.
Collect from the proximal lateral vaginal wall, avoiding cervical contamination.
Fix immediately in 95% alcohol and stain using the Papanicolaou method.
Evaluate 200–400 consecutive cells across three or four different fields.
Compute KI, EI and MI based on the counted cell proportions.
Report findings alongside patient age, menstrual history and possible clinical significance.
Flow Diagram
Quality Control
Compare current smear patterns against the patient's own baseline smears (from at least one complete cycle) to distinguish meaningful hormonal shifts from normal variation.
Cross-correlate cytohormonal index results with serial biochemical hormone assays where available to validate cytologic interpretation accuracy.
Reference Values
Peak Ovulatory Values⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| High maturation in a 60-year-old | Unexpected estrogenic activity for menopausal age | Investigate for exogenous estrogen or estrogen-producing tumor |
| Absent maturation in a 25-year-old | Abnormal for reproductive age | Evaluate for primary/secondary amenorrhea causes |
| Absent maturation, age 52 | Consistent with menopause | No further action if clinically consistent |
Common Errors & How to Avoid Them
Cause: Incorrect sampling site technique.
Prevention: Always sample the proximal lateral vaginal wall specifically for hormonal evaluation.
Cause: No comparison smears obtained across the menstrual cycle.
Prevention: Obtain daily smears over at least one complete cycle before drawing conclusions.
Cause: Inflammatory changes distort cell maturation appearance.
Prevention: Confirm absence of inflammation/cytolysis before hormonal assessment.
Laboratory Tips from the Bench
Always record the patient's age and menstrual history alongside index values — the same MI can mean different things at different life stages.
Count cells from three to four separate fields to reduce sampling bias in the index calculation.
"KI counts nuclei, EI counts cytoplasm" — a quick way to distinguish the two indices.
Important Notes
There are no reliable data linking intermediate degrees of squamous maturation with any single specific hormone.
Cyclic fern-like crystallization of cervical mucus before ovulation, versus liquid non-crystallizing mucus at/after ovulation, can support cytologic ovulation timing.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer.
Clinical Case Study
Apply Your KnowledgePost-menopausal woman with intermittent vaginal spotting. A vaginal smear is submitted for hormonal cytology assessment.
A high level of squamous cell maturation in a post-menopausal woman not on hormone therapy is not consistent with clinical menopause, raising suspicion for an endogenous estrogen source such as an ovarian granulosa cell tumor or thecoma.
- →Cytohormonal findings must always be interpreted alongside age and menstrual history.
- →Unexpected maturation patterns can be an early clue to hormone-producing tumors.
- →Cytology can complement, but not replace, full clinical and biochemical work-up.
Frequently Asked Questions
Cervical cells may not reflect vaginal epithelial hormonal response accurately, so contamination could skew the maturation index results.
No — it is most valuable as a simple, inexpensive supplement, particularly when specialized endocrine laboratories are not readily available.
There is no reliable data linking intermediate degrees of maturation to any single specific hormone, unlike the clear associations seen with full maturation (estrogen) or complete atrophy (estrogen absence).
Quick Revision
10-Minute ReviewKey Takeaways
- Vaginal cytology offers a simple, low-cost window into hormonal status.
- KI, EI and MI quantify different aspects of squamous cell maturation.
- Valid evaluation requires absence of inflammation, medication effects and correct sampling site.
- Results must always be interpreted in light of age and clinical history.
- Unexpected maturation patterns can reveal underlying endocrine pathology.
Competency Checklist
Track Your MasteryReferences
- National Institute of Open Schooling. Histology and Cytology — Lesson 29: Hormonal Assessment.
- Koss LG, Melamed MR. Koss' Diagnostic Cytology and Its Histopathologic Bases.